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Bacterial capsular polysaccharides are virulence factors and are considered T cell–independent antigens. However, the
capsular polysaccharide Sp1 from Streptococcus pneumoniae serotype 1 has been shown to activate CD4
þ T cells in a
major histocompatibility complex (MHC) class II–dependent manner. The mechanism of carbohydrate presentation to
CD4
þ T cells is unknown. We show in live murine dendritic cells (DCs) that Sp1 translocates from lysosomal
compartments to the plasma membrane in MHCII-positive tubules. Sp1 cell surface presentation results in reduction of
self-peptide presentation without alteration of the MHCII self peptide repertoire. In DM-deficient mice, retrograde
transport of Sp1/MHCII complexes resulting in T cell–dependent immune responses to the polysaccharide in vitro and
in vivo is significantly reduced. The results demonstrate the capacity of a bacterial capsular polysaccharide antigen to
use DC tubules as a vehicle for its transport as an MHCII/saccharide complex to the cell surface for the induction of T
cell activation. Furthermore, retrograde transport requires the functional role of DM in self peptide–carbohydrate
exchange. These observations open new opportunities for the design of vaccines against microbial encapsulated
pathogens.
Citation: Stephen TL, Fabri M, Groneck L, Ro ¨hn TA, Hafke H, et al. (2007) Transport of Streptococcus pneumoniae capsular polysaccharide in MHC class II tubules. PLoS Pathog
3(3): e32. doi:10.1371/journal.ppat.0030032
Introduction
The immune response to polysaccharide antigens is
considered T cell–independent [1]. However, emerging
evidence suggests that bacterial polysaccharides from Strepto-
coccus pneumoniae, Bacteroides fragilis, and Staphylococcus aureus
activate CD4
þ T cells in vivo and in vitro due to their
zwitterionic charge motif within each repeating unit [2,3].
Nuclear magnetic resonance (NMR) structural studies of
zwitterionic polysaccharides (ZPSs) such as the capsular
polysaccharides PS A2 from B. fragilis and Sp1 from S.
pneumoniae serotype 1 reveal the formation of extended right-
handed helices with repeated 20 A ˚ negatively charged grooves
and positive charges located on the outer surfaces of the
lateral boundaries [4,5]. A minimum molecular weight of ZPS
.5 kDa and  17 kDa is required for the elucidation of
antigenicity [6]. ZPSs induce CD4
þ T cell activation in the
presence of B cells, monocytes, and dendritic cells (DCs) [7]
and have been demonstrated to correct systemic T cell
deﬁciencies [8]. Animals lacking abCD4
þ T cells fail to
develop abscesses in response to ZPS [9]. We and others have
shown that T cell activation by the ZPS requires the
costimulatory molecules B7–2, CD40, and the major histo-
compatibility complex (MHC) class II protein HLA-DR
[7,10,11]. ZPSs locate in endosomal compartments and co-
immunoprecipitate with HLA-DR [7,12]. These studies
indicate similarities between ZPS and peptide antigen
presentation to CD4
þ T cells by antigen-presenting cells
(APCs).
Antigen processing and presentation to CD4
þT cells by the
MHCII endocytic pathway has been considered strictly
limited to protein antigens [13]. A complex set of interlinked
factors, including the local pH, is likely to inﬂuence the
activity of the processing enzymes. The endosomal pH in
APCs is regulated by proinﬂammatory and anti-inﬂammatory
cytokines [14] and microbial products such as bacterial
lipopolysaccharide (LPS) [15]. LPS triggers enhanced vacuolar
proton ATPase function in immature DCs (iDCs), lower
endosomal or lysosomal pH, and more efﬁcient antigen
processing and a rapid and transient boost of MHCII
synthesis [15,16]. Another important event in antigen
processing and presentation is the removal of class II
invariant chain (CLIP) occupying the peptide binding groove
by the MHCII homolog DM (HLA-DM in humans and H2-M
in mice). DM further stabilizes the empty MHCII molecule
and assists in peptide selection [17–19]. In the absence of DM,
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bound peptides, including CLIP [20]. CLIP also qualiﬁes as an
endogenous regulator in DCs in priming of T helper cells by
antagonizing the polarization towards the TH1 phenotype
[21]. Recent studies show that LPS challenge induces tubules
from lysosomes, which transport MHCII to the cell surface
[22–24]. In the case of protein-loaded lysosomes, protein is
transported in the MHCII tubules to the cell surface for
presentation of the peptide, formation of biological inter-
action with T cells, and induction of T cell–dependent
immune responses [24,25]. Although lysosomal compartments
contain abundant glycosidases that act on sugar linkages,
presumably with high speciﬁcity, they are considered the end
stations for carbohydrates. MHCII tubules formed after LPS
challenge in iDCs do not transport carbohydrates such as
dextran from lysosomes to the cell membrane [24]. However,
Cobb et al. recently showed that a nitric oxide–dependent
processing mechanism of the ZPS PS A1 in early endosomes,
resulting in the generation of low molecular weight, antigenic
fragments [12]. This ﬁnding indicates that antigen processing
is not limited to proteins only. Our recent observation that
blockade of endo/lysosomal acidiﬁcation inhibits carbohy-
drate-induced T cell activation [11] suggests that intra-
vesicular acidic pH and DM activity [26] are required for
polysaccharide binding to MHCII in lysosomal compartments
and/or retrograde transport of carbohydrate/MHCII com-
plexes.
Here, we report the mechanism of retrograde transport of
the bacterial capsular polysaccharide Sp1 from S. pneumoniae
in live cells and the essential role of DM in this process. Sp1
trafﬁcs through endosomal compartments to acidic lysosomes
and is transported in MHCII-positive tubules for presenta-
tion to the cell surface and engagement of T cells. We show
that the DM molecule is required for the retrograde transport
and the cellular immune responses in vitro and in vivo. The
data close a gap in our understanding of the new paradigm of
MHCII presentation of bacterial carbohydrate antigens.
Results
Sp1 Endosomal Trafficking
Sp1 induces T cell activation in the presence of B cells,
monocytes, and DCs [7]. In an experimental model of abscess
formation, besides macrophages [27], CD11c-positive DCs
play an important role. They migrate into the peritoneal
cavity upon Sp1 challenge and are retrieved in the abscess
capsule (Figure 1). Live cell imaging showed that in iDCs, part
of Sp1 is internalized into early endosomes as indicated by
partial co-localization with Rab5 and BCECF-dextran (dex-
tran-29,79-bis-(2-carboxyethyl)-5-(and-6)-carboxyﬂuorescein)
(Figure 2A and 2B). Co-localization of Sp1 with Rab7 and
dextran, markers for late endosomes and lysosomes, and with
LysoTracker, an acidotropic marker for lysosomes, demon-
strated that Sp1-containing compartments fuse with late
endosomes and lysosomes (Figure 2C–2E). Sp1 co-localized
with ovalbumin, a conventional protein antigen processed
and presented by the MHCII pathway (Figure 2F). In order to
Figure 1. DCs in Intraabdominal Abscess Formation Induced by Sp1
(A) Twenty-four hours after intraperitoneal Sp1 challenge, cells of the peritoneal influx were stained with phycoerythrin (PE)–conjugated anti-CD11c
mAb to stain DCs, and analyzed by flow cytometry. Numbers in the right quadrant of the right dot blot represent the percentage of CD11c-positive cells
gated as indicated in the left dot blot and non-gated cells, respectively. FSC-H, forward scatter; SSC-H, sideward scatter.
(B) Immunohistology of abscesses was performed with anti-CD11c mAb. One single CD11c-positive cell in the abscess wall is labeled with a black arrow.
doi:10.1371/journal.ppat.0030032.g001
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Streptococcus pneumoniae Polysaccharide
Author Summary
Microorganisms are comprised of proteins, carbohydrates, lipids,
and nucleic acids. Current immunologic paradigms state that
activation of T lymphocytes required for humoral and cellular
immune responses resulting in immunologic memory to the
pathogens is solely brought about by proteinaceous antigens,
processed and degraded to small peptides, loaded onto major
histocompatibility complex (MHC) molecules, and transported as
MHC/peptide complexes to the cell surface, where the MHC/peptide
complex is recognized by the T cell antigen receptor. The findings of
the present study elucidate the mechanism of MHC class II (MHCII)–
dependent presentation of the bacterial capsular polysaccharide of
Streptococcus pneumoniae serotype 1 (Sp1) that results in effective T
cell activation. Sp1 is transported in MHCII-positive tubules from
lysosomal compartments to the plasma membrane for presentation.
In the absence of the DM molecule, known as an editor and catalyst
of self and foreign peptide exchange, retrograde transport of
carbohydrate/MHCII complexes resulting in dendritic cell engage-
ment with T cells in vitro and T cell–dependent immune responses
to the polysaccharide in vivo fail. The results suggest a fundamental
shift in the immunologic paradigm, offering previously unrecog-
nized opportunities for the design of new classes of vaccines against
infectious diseases.test whether Sp1 is internalized and represented by recycling
receptors, we performed live cell imaging with Rab11b-EGFP
fusion protein, a marker for recycling endosomal compart-
ments. Co-localization of Sp1 with Rab11b was not observed
during an observation interval of 5 min to 24 h in the absence
and presence of LPS treatment (Figure 2G). These results
demonstrate that after internalization, Sp1 gains access to
endocytic compartments where antigenic epitopes are loaded
to MHCII molecules. As presentation of Sp1 by recycling
receptors is largely excluded, the question arises whether and
how Sp1 is transported to the cell surface.
Presentation of Sp1 on the Cell Surface via Retrograde
Transport in MHCII Tubules
Lysosomes constitute the terminal compartment of the
endocytic pathway where exogenous components are gen-
erally degraded. Recent studies with green ﬂuorescent
protein (GFP)–tagged MHCII have shown that after LPS
stimulation of iDCs, MHCII molecules are transported via
tubules that originate from lysosomes to the plasma
membrane [22–24]. We transfected iDCs of C57BL/6 wild-
type (WT) mice with MHCII-GFP (I-Ea-EGFP) to investigate
the presentation mechanism of Sp1. Flow cytometry analysis
revealed that surface expression of assembled I-A and I-E
molecules in transfected DCs was similar to I-A surface
expression in non-transfected cells (Figure S1). Thus, MHCII-
GFP was fully functional and appeared to exhibit the same
general pattern of intracellular transport as endogenous
MHCII in iDCs and mature DCs (mDCs). In iDCs, MHCII-GFP
co-localized extensively with Sp1-Alexa 594 in lysosomes
(Figure 3A). No MHCII-GFP was found on the cell surface.
Within 4 h after LPS stimulation, numerous extensive tubules
Figure 2. Intracellular Trafficking to Lysosomes of Sp1 in WT DCs
(A) Merged fluorescence images of iDCs transfected with Rab5, a marker for early endosomes, and treated with Sp1-Alexa 594 (500 lg/ml) for 10 min.
(B) Merged fluorescence images of iDCs incubated with BCECF-dextran (1 mg/ml), an indicator for early endosomal compartments with a pH of 6 to 7,
for 45 min. iDCs were then incubated with Sp1-Alexa 594 (500 lg/ml) for 10 min.
(C) Merged fluorescence images of iDCs transfected with Rab7, a marker for late endosomes, and incubated for 30 min after treatment with Sp1-Alexa
594 (500 lg/ml) for 10 min.
(D) Merged fluorescence images of iDCs treated simultaneously for 45 min with Sp1-Alexa 594 (500 lg/ml) and dextran-Alexa Fluor 488 (1.5 mg/ml), a
marker for late endosomes/lysosomes.
(E) Merged fluorescence images of iDCs treated simultaneously for 45 min with Sp1-Alexa 488 (500 lg/ml) and LysoTracker Red DND-99 (50 nM), a
marker for lysosomes with a pH of 3 to 5.
(F) Merged fluorescence images of iDCs treated simultaneously for 45 min with Sp1-Alexa 594 (500 lg/ml) and ovalbumin-FITC (1 mg/ml).
(G) Merged fluorescence images of iDCs transfected with Rab11b, a marker for recycling endosomes, and incubated for 1 h after treatment with Sp1-
Alexa 594 (500 lg/ml) for 60 min.
doi:10.1371/journal.ppat.0030032.g002
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Streptococcus pneumoniae Polysaccharideextended from the perinuclear area, which were intensely
labeled for both MHCII and Sp1 (Figure 3B; see also Video
S1). All tubules were yellow, indicating that Sp1 is exclusively
transported in MHCII-positive tubules.
The observation that lysosomes can form dynamic and
motile MHCII/Sp1-containing tubules does not prove that
these structures mediate the transfer of MHCII/Sp1 com-
plexes to the cell membrane. To determine directly whether
these tubules not only move to the periphery but also actually
reach the plasma membrane, we imaged Sp1 transport in DCs
using combined epiﬂuorescence (EPI) and total internal
reﬂectance ﬂuorescence microscopy (TIR-FM) [28]. We
observed Sp1-Alexa 594–containing tubules exiting lysosomes
and associating with the plasma membrane (Figure 3C; see
also Video S2). With time, as the tubule approached the
membrane, the red-colored EPI signal decreased while the
bright yellow TIR-FM signal increased. After 4 h of LPS
stimulation of Sp1-biotin–treated DCs, we detected signiﬁ-
cant amounts of Sp1 on the APC surface by ﬂuorescence-
activated cell sorting (FACS) analysis (Figure 3D), demon-
strating that MHCII/Sp1 fuses with the cell membrane for cell
surface presentation of Sp1. Concomitantly, Sp1-treated DCs
induced engagement with CD4
þT cells, while LPS stimulation
of DCs in the absence of Sp1 did not induce conjugate
formation with T cells (Figure 4A and 4B). Analysis of CD69,
the early activation marker, showed that although the
majority of naı ¨ve CD4
þ T cells form transient interactions
with Sp1-pulsed DCs, a maximum 8% of naı ¨ve T cells are
activated by Sp1-treated DCs at 10 h of incubation (Figure
4C), indicating proper cell surface T cell stimulatory function
of MHCII/Sp1 complexes.
Co-Presentation of Sp1, CLIP, and Self Peptides
The proposed functions of CLIP are that of a precursor
peptide to be exchanged for foreign antigenic peptides, and
of a regulator in priming TH cells by antagonizing the
polarization towards the TH1 phenotype [21]. It was shown
that regardless of the presence and type of protein antigen
provided to mDCs and loaded onto MHCII, the number of
surface CLIP/MHCII complexes remained unchanged [21].
Here, in contrast to ovalbumin as a control antigen, the
incubation of maturing DCs with Sp1 resulted in a 57%
decrease in D-CLIP surface expression (Figure 5A), whereas
HLA-DR expression remained unaltered. The ratio of the
mean ﬂuorescence intensities (MFIs) of CLIP/MHCII for iDCs,
mDCs, and ovalbumin-treated DCs was 0.5, and 0.3 for Sp1-
treated DCs. This observation suggests that CLIP is displaced
when Sp1 is present and that reduced CLIP surface
presentation modulates Sp1-mediated T cell immune re-
sponses. To investigate whether Sp1 treatment also affects
presentation of self peptides other than CLIP, we performed
matrix-assisted laser desorption and ionization mass
spectrometry (MALDI-MS) of MHCII precipitates from
Figure 3. Export of Sp1 from Lysosomes to the Cell Membrane in MHCII-GFP–Positive Tubular Structures in Live DCs
(A) iDCs transfected with MHCII-GFP were treated for 30 min with Sp1-Alexa 594 (500 lg/ml) and then analyzed by live cell imaging using confocal
microscopy. In merged fluorescence images, Sp1 co-localizes extensively with MHCII in lysosomes. No MHCII is found on the cell surface.
(B) iDCs transfected with MHCII-GFP were pre-incubated for 30 min with Sp1-Alexa 594 (500 lg/ml) and then treated with LPS for 4 h. Merged
fluorescence live cell images of confocal microscopy demonstrate that Sp1/MHCII-positive tubular structures emanate from lysosomes in a perinuclear
region and transit to the cell membrane. A single translocation Sp1/MHCII-positive tubule is labeled with white arrows (see Video S1).
(C) iDCs previously transfected with MHCII-GFP and pre-incubated for 30 min with Sp1-Alexa 594 (500 lg/ml) were stimulated for 4 h with LPS.
Combined TIR-FM/EPI microscopy reveals exit of Sp1-containing tubules from lysosomes (red) and their association with the plasma membrane (bright
yellow). Tubules are labeled with white arrows (see Video S2). Scale bar, 10 lm.
(D) After treatment with Sp1-biotin for 30 min, iDCs were incubated for various time intervals with LPS, and their cell surface was stained with FITC-
conjugated streptavidin. Presentation of Sp1-biotin on the DC surface was quantified by flow cytometry.
doi:10.1371/journal.ppat.0030032.g003
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Streptococcus pneumoniae PolysaccharideT2.DR4.DM transfectants. The composition of the self-
peptide repertoire with CLIP as the major representative
remained unaltered when we compared MALDI-MS spectra
obtained in the absence and presence of Sp1 (Figure 5B). In
summary, Sp1 provided to DCs and loaded onto MHCII leads
to a reduction in the number of surface self-peptide/MHCII
complexes with CLIP/MHCII as the principal subset.
Requirement of DM for T Cell–Dependent Immune
Responses to Sp1 In Vivo
Sp1 is a highly charged molecule and might be exchanged
for peptides in an antigen site due to its stronger electrostatic
forces. However, it is possible that DM as a catalyzer of
peptide exchange and editor of peptide/MHCII binding
might also be required for carbohydrate/peptide exchange.
To assess the catalytic activity of DM, we ﬁrst investigated
whether DM is required for T cell–dependent immune
responses to Sp1 in vivo. In an experimental model for
abscess formation, unlike WT mice, animals lacking DM are
not able to form abscesses in response to Sp1 (Figure 6A).
Twenty-four hours before challenge, CD4
þ T cells from WT
mice were adoptively transferred to DM
 /  mice per intra-
venous route to compensate for the 3- to 4-fold reduction of
mature CD4
þ T lymphocytes and for the diminished T cell
repertoire selection of DM
 /  mice [29]. Analysis of the cells
migrating into the peritoneal cavity 24 h after polysaccharide
challenge showed that the total number of cells did not differ
in WT and DM
 /  mice (Figure 6B, left panel). In both groups,
about 40% of inﬂux cells were macrophages (not shown). In
contrast to WT mice, the peritoneal inﬂux of CD4
þT cells was
signiﬁcantly reduced in DM
 /  mice (Figure 6B, right panel).
Adoptive intraperitoneal transfer of Sp1-pulsed APCs from
WT mice fully reconstituted the CD4
þ inﬂux in DM
 /  mice.
Analysis of the peritoneal lavage did not reveal a CD4
þ T cell
inﬂux to the APC transfer alone. These ﬁndings indicate that
the CD4
þ T cell inﬂux in response to Sp1 depends on DM
expression in peritoneal APCs.
Requirement of DM for Sp1 Retrograde Transport
We investigated the role of DM in the retrograde transport
of Sp1 in DCs and in the initiation of T cell–dependent
immune responses in vitro. We transfected iDCs of DM
 / 
mice of the H-2b haplotype with I-Ea-EGFP. The dependency
of I-A molecules on DM to function in antigen presentation
has been characterized extensively in the DM
 /  mouse strain
used [29–31]. It also has been shown that I-E is dependent on
DM for peptide loading, as evidenced by the abundance of
CLIP occupying the MHCII groove in DM
 /  mice [32]. Flow
cytometry analysis revealed that after LPS stimulation of
DM
 /  iDCs, assembled I-E and I-A molecules appeared at the
cell surface with similar quantities and kinetics as in WT DCs
(Figure S2). In DM
 /  iDCs, MHCII co-localized extensively
with Sp1 in lysosomes (Figure 7A). Within 4 h of stimulation
with LPS, tubules extended from the perinuclear area, which
were intensely labeled for MHCII-GFP and were devoid of
Sp1-Alexa 594 (Figure 7B). At this time point and within the
next 6 h, all tubules were green, indicating that Sp1-Alexa 594
is not transported in tubules with MHCII-GFP in DCs lacking
DM. To provide functional evidence for the requirement of
DM for Sp1 presentation in DCs, we examined the effect of
the absence of DM on APC/T-cell engagement in vitro. iDCs
from DM
 /  and WT mice were pulsed with Sp1-Alexa 594 in
the presence or absence of LPS for different time intervals.
Pulsed DCs were incubated with carboxyﬂuorescein succini-
Figure 4. Interaction of DCs with Naı ¨ve CD4
þ T Cells
iDCs expressing MHCII-GFP and CFSE-labeled CD4
þ T cells were used for live cell imaging of DC/T-cell immune interactions. Live fluorescent confocal
microscopy imaging was performed at 4 h of LPS treatment. CD4
þ T cells are indicated by a ‘‘T’’.
(A) DCs left untreated.
(B) iDCs were pulsed for 30 min with Sp1 (500 lg/ml) and then treated with LPS. Scale bar, 10 lm.
(C) iDCs were treated with Sp1 (100 lg/ml) for 45 min or left untreated before incubation with naı ¨ve CD4
þ T cells in the presence of LPS (100 ng/ml).
CD69 surface expression on CD4
þ T cells was analyzed at indicated time points. Black line, non-Sp1-treated DCs; gray line, Sp1-treated DCs.
doi:10.1371/journal.ppat.0030032.g004
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Streptococcus pneumoniae Polysaccharidemidyl ester (CFSE)–labeled CD4
þ T cells from WT mice and
examined for DC/T-cell conjugate formation by ﬂuorescent
microscopy. After the addition of LPS, WT DCs showed a
signiﬁcant increase of APC/T-cell conjugates, which peaked at
4 h to 10 h (Figure 7C). In contrast to WT DCs, DM
 /  DCs
pulsed with Sp1-Alexa 594 did not induce signiﬁcant
conjugate formation with CD4
þ T cells.
Discussion
The new paradigm of MHCII-restricted presentation of
carbohydrates leaves open obvious questions regarding the
precise mechanism of bacterial capsular carbohydrate inter-
actions with MHCII molecules. Here we provide evidence that
internalization of polysaccharides is followed by intracellular
transport and presentation on the cell surface by newly
synthesized MHCII molecules. We show that in DCs, Sp1
migrates in tubules as carbohydrate/MHCII complexes to the
cell surface to induce T cell–dependent immune responses in
vitro and in vivo. Sp1/MHCII retrograde transport requires
the editor protein DM.
Intracellular tracking of Sp1 reveals partial co-localization
with BCECF-dextran and Rab5, markers for early endosomes,
that might reﬂect different pathways for Sp1-containing
pinocytic and endocytic vesicles [33] or an intermediate
status during fast maturation of Sp1-containing vesicles into
late endosomes and lysosomes. In early endosomes, Sp1 could
be subjected to oxidation by free radicals as was shown for PS
A1 [12]. There is an increasing acidiﬁcation of Sp1-containing
intracellular compartments. We previously demonstrated
that Sp1-induced T cell activation depends on the acidic
lysosomal pH and that Sp1 induces maturation of human
monocyte-derived DCs [11]. Besides proteases, lysosomes also
contain abundant glycosidases, such as fucosidases and
galactosidases [34]. At a later stage of the endocytic pathway
at an optimal acidic pH of maturing DCs [15], glycosidases
may trim Sp1 to smaller molecular sizes, forming conforma-
Figure 5. Effect of Sp1 on Self-Peptide Presentation
(A) Flow cytometry analysis of iDCs, mDCs, ovalbumin (200 lg/ml)–treated, and Sp1 (200 lg/ml)–treated mDCs stained for CLIP and HLA-DR. Solid lines
indicate the isotype-stained controls. The MFI is indicated in the upper corner.
(B) MALDI-MS analysis of self peptides derived from T2.DR4.DM transfectants, without and with Sp1 treatment (200 lg/ml). MHCII HLA-DR molecules
were precipitated with mAb L243. * indicates CLIP(81–102) m/z ¼ 2333.4; **, CLIP(81–103) m/z ¼ 2543.4; and ***, CLIP(81–104) m/z ¼ 2674.5.
doi:10.1371/journal.ppat.0030032.g005
Figure 6. DM Dependency of Sp1-Mediated T Cell–Dependent Immune
Responses
(A) WT and DM
 /  were challenged with Sp1 and intraperitoneal abscess
formation was measured after 6 d.
(B) The total cellular influx (left panel) and the influx of CD4
þT cells (right
panel) into the peritoneal cavity was evaluated in WT and of DM
 /  mice
24 h after Sp1 challenge and/or adoptive transfer.
doi:10.1371/journal.ppat.0030032.g006
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Streptococcus pneumoniae Polysaccharidetions that facilitate Sp1 anchoring and binding to MHCII and
promote optimal generation of T cell epitopes.
In contrast to non-charged dextrans, Sp1 is transported
from lysosomes to the cell surface in MHCII-positive tubules
like conventional protein antigens HEL and Ova [24,25].
Confocal, EPI/TIR ﬂuorescence microscopy, and FACS
analyses demonstrate time-dependent retrograde transport
and cell surface presentation of Sp1 on maturing DCs,
indicating fusion of Sp1-carrying tubules with the plasma
membrane for formation of an immunological synapse
required for proper activation of T cells. Presentation of
Sp1 on the DC surface results in conjugate formation with a
considerable number of T cells from non-Sp1–primed naı ¨ve
mice. Although mDCs are known to attract and cluster with
naı ¨ve T cells [35], it is possible that T cells from non–germ-
free animals that are colonized with the ubiquitous gut
organism B. fragilis are primed by the ZPS from B. fragilis and
cross-react with Sp1 [36]. Indeed, about 8% of the naı ¨ve CD4
þ
T cells become activated by Sp1-treated DCs. The drastically
different immunogenic properties of Sp1 are brought about
by speciﬁc biochemical characteristics by which Sp1 distin-
guishes itself from other carbohydrates such as dextrans. At
an acidic lysosomal pH similar to the Sp1 isoelectric point of
3.5 (unpublished observation), an optimal equilibrium of
positively charged free amino groups and negatively charged
carboxyl groups is available and provides a large number of
binding sites to associate with MHCII molecules. The high
density of alternating opposite charges is exposed on the
outmost surface of the molecule. Maximum binding would be
achieved via abundant electrostatic interactions supple-
mented by the potential for numerous hydrogen bonds to
hydrophilic hydroxyls and van der Waals interactions.
The proper balance of TH1a n dT H2i m m u n o l o g i c
responses is critical to maintain balance in the immune
system’s task to ﬁght microbial antigens. It has been shown
that increased representation of CLIP/MHCII complexes
antagonize polarization of T cells towards the TH1 phenotype
[21]. Here, we show reduction of CLIP cell surface presenta-
tion in mDCs possibly caused by antigenic exchange of CLIP
with Sp1 and/or modulation of MHCII/self-peptide retro-
grade transport by Sp1. Inhibition of presentation of CLIP/
MHCII in Sp1-treated mDCs might contribute to the
establishment of a TH1/TH2b a l a n c et o w a r d st h eT H1
phenotype as has been described for the ZPS of the symbiotic
Figure 7. DM Dependency of Sp1 Retrograde Transport in MHCII-Positive Tubules
(A) DM
 /  iDCs transfected with MHCII-GFP were treated for 30 min with Sp1-Alexa 594 (500 lg/ml) before live cell imaging by confocal microscopy.
Merged fluorescence images of DM
 /  iDCs reveal co-localization of Sp1 with MHCII-GFP in lysosomes. No MHCII is found on the cell surface.
(B) DM
 /  iDCs transfected with MHCII-GFP were pre-incubated with Sp1-Alexa 594 (500 lg/ml) for 30 min and then treated with LPS for 4 h. Merged
fluorescence live cell images of confocal microscopy demonstrate that DCs form MHCII-GFP–positive tubules by 4 h of stimulation with LPS that extend
from the perinuclear area to the cell surface (arrows) while Sp1-Alexa 594 remains lysosomal (right panel). Scale bar, 10 lm.
(C) DCs from WT or DM
 /  mice expressing MHCII-GFP were stimulated with Sp1-Alexa 594 (500 lg/ml) for 30 min and LPS for various time intervals.
Immune interactions with CFSE-labeled WT T cells were analyzed by live cell fluorescent microscopy imaging (see also Figure 2E and 2F).
doi:10.1371/journal.ppat.0030032.g007
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Streptococcus pneumoniae Polysaccharideintestinal bacteria B. fragilis [8]. It might also be responsible
for low Sp1-speciﬁc antibody production (unpublished data)
and might modulate the immune response to ZPS during
abscess formation and adhesion.
Beyond the functional role of DM in peptide exchange, our
data suggest an extension to antigenic exchange with
carbohydrates. Three functions have been described for
DM: 1) to catalyze the removal of CLIP or non-CLIP peptides
and their exchange by heterogeneous peptides [17–19]; 2) to
serve as a molecular chaperone, preventing non-speciﬁc
aggregation of the temporarily empty ab dimers following
CLIP release [37]; and 3) to function as a peptide editor,
positively selecting peptides that can stably bind to a
particular class II allele [18,38]. Besides facilitating Sp1
binding through catalytic release of CLIP and other peptides,
DM might select those Sp1 length variants for binding that
form the most stable complexes due to their optimal
structural and electrostatic features. Although in DM-
deﬁcient DCs accumulation of Sp1 in endocytic compart-
ments, retrograde transport, and surface expression of
MHCII complexed with either CLIP or self peptides is
normal, they are inefﬁcient in transporting Sp1 from
endocytic compartments to the cell surface and initiating
conjugate formation with naı ¨ve CD4
þ T cells.
So far, it is not possible to rule out internalization and
presentation of ZPS by recycling MHCII or presentation
similar to superantigens [7,12]. Recycling MHCII binds to
peptides in early endosomes and trafﬁcs between early
endosomes and cell membrane. Indeed, Sp1 partially co-
internalizes with transferrin (not shown), a marker for
recycling receptor-mediated endocytosis. However, Sp1 is
directed from early endosomal compartments to late endo-
somes and lysosomes, where it co-localizes with newly
synthesized MHCII and does not locate in recycling endocytic
Rab11b-positive compartments. Furthermore, the depend-
ency of Sp1 biological activity on DM and on the retrograde
tubular transport of MHCII clearly argues against a pre-
sentation mechanism similar to superantigens and by
recycling MHCII molecules.
Taking the results together, we show that bacterial
polysaccharide–induced APC/T-cell conjugate formation and
T cell–dependent immune responses depend on retrograde
transport via MHCII tubules and the functional role of DM.
Materials and Methods
Antigens. S. pneumoniae type 1 capsular polysaccharide complex was
obtained from the American Type Culture Collection (http://www.
atcc.org) and further puriﬁed to obtain homogeneity as described
previously [11]. High-resolution (500 MHz) proton NMR spectroscopy
[5] revealed that Sp1 was free of contaminating protein and nucleic
acids. Endotoxin was not detectable in Sp1 by the limulus test with
sensitivity of ,8 pg LPS/mg Sp1. As control antigens, ovalbumin–
ﬂuorescein isothiocyanate (FITC), ovalbumin–Alexa Fluor 594,
dextran–Alexa Fluor 488, and dextran–Texas Red Molecular Probes
were used (http://probes.invitrogen.com).
Inhibitors and markers. For intracellular tracking, BCECF-dextran,
LysoTracker Red DND-99, dextran–Alexa Fluor 488, and ovalbumin-
FITC were obtained from Molecular Probes.
Labeling of ZPS. Sp1 is a linear polymer of an average molecular
size of 90 kDa corresponding to 167 trisaccharide repeating units
with a respective molecular size of 537 Da. Each repeating unit of
Sp1 contains one positively and two negatively charged groups with
galacturonic acid (GalA, residues a and c) and 2-acetamido-4-amino-
2,4,6-trideoxygalactose (Aat, residue b) with a sequence of ﬁ3)-a-D-
GalA (a)-(1ﬁ3)-a-D-Aat (b)-(1ﬁ4)-a-D-GalA (c)-(1ﬁ [5,39]. The
adjacent hydroxyl groups on residue c (molecular weight 175) were
oxidized by sodium m-periodate (Sigma, http://www.sigmaaldrich.
com) treatment in molar ratios ranging from 1:0.1 to 1:0.5 for 90
min at room temperature in the dark to create highly reactive
aldehyde functional groups [40]. The reaction was stopped by
addition of ethylene glycol (Sigma). After gel ﬁltration chromatog-
raphy with a PD-10 column (Amersham, http://www.amersham.com),
Sp1 was labeled by formation of covalent hydrazone linkages
between aldehydes and EZ-Link Biotin-Hydrazide (Pierce, http://
www.piercenet.com), Alexa Fluor 488 hydrazide, and Alexa Fluor 594
hydrazide (Molecular Probes) following the instructions of the
manufacturer. After reduction of residual aldehydes of biotinylated
Sp1 (Sp1-biotin), Alexa Fluor 488–labeled Sp1 (Sp1-Alexa 488), and
Alexa Fluor 594–labeled Sp1 (Sp1-Alexa 594) by base treatment at
pH 9.0 for 60 min, the glycoconjugate was separated from unbound
labeling agents by three consecutive runs on PD-10 columns. The
degree of biotinylation was determined with the ImmunoPure 2-(49-
hydroxyazobenzene benzoic acid) (HABA) and ImmunoPure Avidin
(Pierce) reagents, following the instructions of the manufacturer.
This method allows the calculation of mol biotin per mol Sp1 and
number of biotin molecules per repeating units. Labeled Sp1 carried
a biotin molecule on every 20th repeating unit (Sp1-biotin), which
corresponds to one label per 11-kDa fragment by
1HN M R
spectroscopy and showed the same chemical shifts as native Sp1
(Figure S3A and S3B). The additional signals obtained for Sp1-biotin
originated from EZ-Link Biotin-Hydrazide (Figure S3B, upper
spectrum). All mice challenged with Sp1-biotin developed intra-
abdominal abscesses to the same degree as native Sp1 (Figure S3C).
Sp1 labeled with Alexa Fluor hydrazide 488 (Sp1-Alexa 488) or Alexa
Fluor hydrazide 594 (Sp1-Alexa 594) preserved its intact structure
and in vivo immune responses (not shown). These controls
demonstrated that the biological activity of labeled Sp1 used in
our studies is indistinguishable from that of unlabeled Sp1.
NMR spectroscopy. NMR spectra were obtained from a sample of 2
mg of puriﬁed Sp1, Sp1-biotin, or Sp1-Alexa 488, which was
exchanged with
2H2O once and redissolved in 0.7 ml of
2H2Oa s
described previously [5]. NMR experiments were performed on a
Bruker DRX 500 instrument (Bruker, http://www.bruker.de) with a
proton resonance frequency of 500.13 MHz. The
1H spectra were
recorded at 80 8Ci n
2H2O using presaturation to suppress the water
signal. Chemical shifts were referenced in relation to
1H
2HO
resonance at 4.36 ppm.
Abscess induction studies and evaluation of the peritoneal inﬂux.
Animal experiments were performed in accordance with the guide-
lines of German animal protection legislation (license number
50.203.2-K 16,3/02). In abscess induction studies, B6129SF2/J (WT)
and H2-Dma
tm1Luc (DM
 / ) [29] obtained from Charles River Labo-
ratories (http://www.criver.com) were injected intraperitoneally with
Sp1 (100 lg of Sp1 in PBS mixed with sterile cecal content adjuvant
[SCCA]; 1:1 v/v, 0.2 ml total volume) [9]. Then, 24 h before challenge, 2
3 10
7 CD4
þ T cells (.95% purity) from WT mice were adoptively
transferred to DM
 /  mice per intravenous route. Six days after
challenge, mice were macroscopically examined for the presence of
abscesses within the peritoneal cavity by two double-blinded
examiners. Abscesses were isolated and their diameter was measured.
The cellular inﬂux into the peritoneal cavity was assessed at 24 h
following challenge with Sp1. As in abscess induction studies, 2310
7
CD4
þ T cells from C57BL/6 (WT) mice obtained from Charles River
Laboratories were adoptively transferred to DM
 /  mice per intra-
venous route 24 h before challenge. WT mice were challenged
intraperitoneally with Sp1. DM
 /  mice were either challenged
intraperitoneally with Sp1, Sp1 plus 2 3 10
7 WT APCs, or 2 3 10
7
WT APCs alone. APCs were puriﬁed from the peritoneal lavage
followed by CD4
þT cell depletion (,0.05% CD4
þT cells) of WT mice
challenged 24 h before adoptive transfer. Mice underwent peritoneal
lavage with 4 ml of ice-cold PBS. A total cell count was performed by
trypan blue staining with a hemocytometer. Each sample was then
analyzed by ﬂow cytometry for different cell types. The absolute
number of each respective cell type present was calculated by taking
its respective frequency and multiplying it by the total number of
cells per ml lavage obtained from each mouse. In each experiment,
four to six mice per group were tested. The experiment was
performed three times in an independent manner.
Immunohistology. Frozen sections of abscesses were ﬁxed in cold
acetone for 10 min followed by blocking of endogenous peroxidase
with peroxidase blocking solution (DAKO, http://www.dako.com) for
10 min at room temperature. The CD11c antibody (N418, super-
natant; 1:100 diluted) was then overlayed and the slides incubated in a
humid chamber for 45 min. With TRIS washes between every step, a
biotinylated link antibody (Becton Dickinson, http://www.
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Streptococcus pneumoniae Polysaccharidebdbiosciences.com) was applied for 45 min followed by a streptavi-
din-alkaline phosphatase (DAKO) for 10 min. After another wash, the
substrate (Vector NovaRed; Vector Laboratories, http://www.
vectorlabs.com) was added and the slides were incubated in the dark
for 20 min. After a TRIS wash, the slides were counter stained,
mounted, and viewed using a Zeiss Axiophot microscope with
photographic capabilities (http://www.zeiss.com).
APCs and cell culture. DCs were generated from mouse bone
marrow by adapting a previously described method [41]. In brief,
bone marrow cells from H2-Dma
tm1Luc [29] (DM
 / ) and C57BL/6 (WT)
mice that have a mutation that abolishes production of the MHCII I-
Ea chain [31,42] were cultured in RPMI supplemented with 5% FBS,
500–1,000 U recombinant mouse granulocyte/macrophage-colony
stimulating factor (GM-CSF), 20 lg per ml gentamicin, and 50 lM
2-mercaptoethanol (DC medium). DC medium was exchanged in two-
day intervals. DCs were isolated by magnetic cell sorting with a
CD11c-speciﬁc monoclonal antibody (mAb) (Miltenyi Biotec, http://
www.miltenyibiotec.com). CD11c-positive iDCs were imaged on days
4 and 5 of culture. mDCs were generated by adding LPS O26:B6 (100
ng/ml) (Sigma) to disaggregated and replated cultures.
Infection of proliferating precursors with retrovirus containing I-
Ea-EGFP was performed on day 2 by adapting a method described
previously by Chow and coworkers [24]. I-Ea-EGFP, kindly provided
by I. Mellman, was cloned into LZRS-pBMN using EcoRI sites. This
viral vector was transfected into UNX-ecotropic cells using calcium
chloride. Virus was collected in DC medium for 24 h, supplemented
with polybrene and HEPES, and added to the DC culture for
infection. Cells were spun at 32 8C, 2,500 rpm for 2 h. Virus was
removed and fresh medium added. Expression was assayed 48 h after
infection.
Localization of Sp1 in recycling, early, and late endosomes was
performed by adenoviral infection of live dendritic cells with
Rab11b-EGFP, Rab5-GFP, and Rab7-GFP–containing mammalian
expression plasmids [43]. DNA fragments containing Rab fusion
protein constructs and CMV promoter were ampliﬁed in the double
digested promoter-less transfer vector pEntry148AU-MCS. For pack-
aging into adenovirus particles, constructs were recombined into
pAd/PL-DEST vector (Invitrogen, http://www.invitrogen.com). Adeno-
viral stocks were produced in 293A cells after transfection with
plasmid DNA and Lipofectamine. Infection of DCs with Rab5-EGFP,
Rab7-EGFP, and Rab11b-EGFP was performed on day 4. iDCs were
spun at 2,500 rpm at 37 8C for 120 min in virus-containing medium
supplemented with 10 mM HEPES. After replacement with DC
medium, expression was checked by ﬂuorescence microscopy after 24
h. Transfection efﬁciency was 50% to 70%.
Human DCs were differentiated from peripheral blood mono-
nuclear cells as described [44]. Monocytes were isolated from
peripheral blood mononuclear cells by positive selection by anti-
CD14 magnetic beads (Miltenyi Biotec) and cultured in complete
RPMI medium containing 50 ng/ml GM-CSF and 3 ng/ml IL-4.
Maturation was induced at day 4 by the addition of LPS from
Salmonella abortus equi (1 lg/ml) (Sigma).
Flow cytometry. Staining of surface molecules was performed
using PE- or FITC-conjugated anti-CD4 (clone L3T4), anti-CD11c
(clone Hl3), anti-CD69 (clone HI.2F3), anti-I-Eab (clone 14.4.4S), anti-
I-Ab (clone AF6–120.1), anti-HLA-DR/CLIP complex (clone Cer.-
CLIP), and anti-HLA-DR (clone L243) (BD Pharmingen, http://www.
bdbiosciences.com). For Sp1 surface presentation studies, iDCs were
incubated for 30 min at 37 8C without or with Sp1-biotin (200 lg/ml),
washed, and incubated for 30 min to 8 h at 37 8C in LPS-containing
medium (100 ng/ml) before staining with streptavidin-FITC (Sigma)
for 30 min and washing. Cells prepared for ﬂow cytometry were
analyzed—after gating for viable cells by forward and side scatter and
by propidium iodide staining—by FACScan (Becton Dickinson) using
CELLQuest software (Becton Dickinson). The results were expressed
as MFI, or as percentage (%) of ﬂuorescence-labeled APCs of the
whole APC population.
Live ﬂuorescent microscopy. To investigate intracellular trafﬁck-
ing of Sp1, live cell imaging was performed. Cells were plated for 30
min on poly-D-lysine–pre-coated number 1.5 coverslips attached to
35-mm dishes (MatTek, http://www.mattek.com), and fresh medium
was added. To study mechanisms of internalization of Sp1, cells were
incubated with competitors or chemical inhibitors for 30 min at 4 8C
or 37 8C before Sp1 treatment. To monitor Sp1, APCs were loaded
with markers for cellular compartments before or at the same time
point of Sp1 addition. Cells were washed before and after Sp1
treatment three times in ice-cold medium. Inverted ﬂuorescent
microscopy was performed on an Olympus IX81 microscope (http://
www.olympus-europe.com/microscopes/index.htm). Temperature
control at 37 8C was achieved with a heating dish. Acquisition was
performed using AnalySIS Imaging System software (Olympus, http://
www.olympus.de). Confocal microscopy was done on a PerkinElmer
UltraView LCI spinning disc system (http://las.perkinelmer.com)
equipped with a suitable multi-band beamsplitter and a MellesGriot
Omnichrome 643-RYB-A02 ArKr gas laser (http://www.mellesgriot.
com) providing 488-nm and 568-nm lines for excitation. A Nikon
Plan Fluor 3100 1.3NA oil immersion objective (http://www.nikon.
com) and 525/50 and 607/45 emitter ﬁlters were used for GFP, FITC,
Alexa 488, and Alexa 594, and Texas Red stains, respectively.
Multi-color TIR-FM and EPI was performed on an Olympus
Biosystems Cell-R system equipped with a stabilized Xenon arc lamp
and dual coupling for Coherent Sapphire 488–20 and Compass 250M-
50 diode lasers (http://www.coherent.com) providing 488 nm and 532
nm excitation light, respectively. On confocal microscopy, EPI, and
TIR-FM systems, environmental condition was controlled by a custom
incubator (EMBL GP 168) that provides a 37 8C and 5% CO2
atmosphere. Images were exported to TIFF images, processed using
Adobe Photoshop version 6.0 (http://www.adobe.com), and converted
into QuickTime movies using Graphic Converter version 3.8
(Softguide, http://www.softguide.de).
APC/T-cell engagement. Investigation of DC/T-cell conjugate
formation was performed as previously described [45]. In brief, DCs
from C57BL/6 WT and DM
 /  mice were loaded with Sp1-Alexa 594
for 30 min or left untreated and washed. DCs (0.5310
5/ml) were then
treated with LPS (100 ng/ml) for different time intervals, washed, and
mixed with CFSE-labeled CD4
þ T cells (1.5 3 10
5) from C57BL/6 WT
mice. Cells were centrifuged for 5 min at 50g to increase cell
interactions, and incubated at 37 8C for 20 min. The cells were gently
transferred to poly-D-lysine–pre-coated number dishes. After incu-
bation at 37 8C for 30 min, T-cell–DC conjugates were subjected to
imaging by ﬂuorescent microscopy. CFSE-labeled T cells were
distinguished from GFP-labeled DCs by morphology. Three inde-
pendent experiments were performed and the number of CFSE-
positive CD4
þT cells interacting with 100 Sp1-Alexa 594–positive DC
was counted in a blinded manner as previously described [22].
For the investigation of WT CD4
þT cell activation induced by Sp1-
treated DCs, the same protocol as for DC/T-cell conjugate formation
was applied with some modiﬁcations. DCs were treated with 100 lg/ml
Sp1 for 45 min or left non-treated. Analysis of the expression of CD69,
the early activation marker on CD4
þ T cells, was performed by ﬂow
cytometry at different time points after addition of T cells to DCs.
Mass spectrometry. T2.DR4.DM transfectants, expressing the
MHCII molecules HLA-DR4 and DM, respectively, were maintained
in RPMI 1640 supplemented with 10% FCS. T2 is a BxT cell hybrid
with a large deletion in the MHCII locus and does not express
endogenous MHCII proteins. Cells at a density of 6310
5 cells/ml were
treated with Sp1 (200 ug/ml) for 20 h, washed with PBS, and lysed (63
10
6/ml) at 4 8C in lysis buffer of 20 mM and 5 mM MgCl containing
1% Triton X-100 and protease inhibitors. The cells were precipitated
with mAb L243 (recognizing antigen/HLA-DR complexes) conjugated
to sepharose beads. Peptides were eluted with 0.1% triﬂuor-acetic
acid. MALDI-MS analysis was done as described [21] on a Reﬂex III
mass spectrometer (Bruker).
Statistical analysis. Comparison of groups with regard to abscess
formation was made by chi-square analysis. Results of the various
groups in peritoneal cellular inﬂux and APC/T-cell engagement
assays were compared by Student’s t test.
Supporting Information
Figure S1. Biological Activity of C57BL/6 DCs Transfected with
MHCII Protein I-Ea-EGFP
CD11c-positive DCs non-transduced or transduced with MHCII
protein I-Ea-EGFP were treated in medium alone or with LPS for 4
h and 10 h. Surface expression of the MHCII proteins I-A and I-E was
determined by ﬂow cytometry.
Found at doi:10.1371/journal.ppat.0030032.sg001 (56 KB PPT)
Figure S2. Biological Activity of DM
 /  DCs Transfected with MHCII
Protein I-Ea-EGFP
CD11c-positive DM
 /  DCs non-transduced or transduced with
MHCII protein I-Ea-EGFP left untreated or were treated with LPS
for 4 h and 10 h. Surface expression of the MHCII proteins I-A and I-
E was determined by ﬂow cytometry.
Found at doi:10.1371/journal.ppat.0030032.sg002 (49 KB PPT)
Figure S3. Structure and Functional Activity of Biotin-Labeled Sp1
(A)
1H NMR spectra of native Sp1, (B) EZ-Link Biotin-Hydrazide
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Streptococcus pneumoniae Polysaccharide(upper spectrum), and Sp1-biotin (lower spectrum) were recorded at
70 8C. (C) Sp1 and Sp1-biotin were tested in an animal model for
intraabdominal abscess formation. Negative control: Challenge with
SCCAalone.Eachdotrepresentsthetotalabscessdiameterpermouse.
The bar illustrates the median of total abscess diameters per group.
Found at doi:10.1371/journal.ppat.0030032.sg003 (1.0 MB PPT)
Video S1. Export of Sp1 from Lysosomes to the Cell Periphery in
MHCII-GFP–Positive Tubular Structures in Live DCs
Confocal imaging shows a C57BL/6 DC expressing MHCII-GFP
(green), loaded with Sp1-Alexa 594 (red) for 30 min, and exposed to
LPS for 4 h. MHCII-GFP partially localizes in late endosomes and
lysosomes and on the cell surface. Sp1-Alexa 594 accumulates
intracellularly in lysosomal compartments and is transported in
MHCII-GFP tubules extending from the perinuclear lysosomal
compartments to the cell surface. Time interval: 0.25 s/frame. Time
duration: 1 min.
Found at doi:10.1371/journal.ppat.0030032.sv001 (118 KB MOV)
Video S2. Export of Sp1 from Lysosomes for Presentation on the Cell
Membrane in MHCII-GFP–Positive Tubular Structures in Live DCs
Combined TIR-FM and EPI live cell imaging shows a C57BL/6 DC
expressing MHCII-GFP, loaded with Sp1-Alexa 594 for 30 min, and
exposed to LPS for 4 h. Red-colored tubules show Sp1-containing
compartments exiting lysosomes, while the bright yellow–colored
structures represent Sp1-containing tubules reaching and associating
with the plasma membrane. Some tubules are indicated by white
arrows. Time interval: 0.2 s/frame. Time duration: 2.5 min.
Found at doi:10.1371/journal.ppat.0030032.sv002 (584 KB MOV)
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